Intraepidermal nerve fiber density and nerve conduction study parameters correlate with clinical staging of diabetic polyneuropathy

Diabetes Res Clin Pract. 2013 Jan;99(1):24-9. doi: 10.1016/j.diabres.2012.09.026. Epub 2012 Sep 21.

Abstract

Aim and methods: To assess the usefulness of the diagnostic and staging criteria for diabetic polyneuropathy (DP) by the Diabetic Neuropathy Study Group in Japan (DNSGJ) we examined clinical features, intraepidermal nerve fiber densities (IENFD) and nerve conduction studies (NCS) and coefficient of variation of the R-R intervals (CVR-R) in 44 patients with diabetes.

Results: The patients were classified into stage I (n=20), II (n=6), III+IV (n=12), and V (n=6) according to the staging criteria by DNSGJ. IENFD decreased as stages progressed (13.8±7.1 fiber/mm in stage I to 0.8±1.3 fiber/mm in stage V). Compound motor and sensory action potential and motor and sensory nerve conduction velocity decreased with progressing stage. F-wave latency prolonged as stages progressed. CVR-R decreased with progressing stage (4.41%±2.65% in stage I to 1.33%±0.57% in stage V). IENFD correlated with the various parameters of NCS (r=0.378-0.636, p<0.05) and CVR-R (r=0.399, p=0.007).

Conclusions: Clinical staging for DP by DNSGJ reflects the results of small and large fiber neuropathy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials
  • Adult
  • Aged
  • Diabetes Mellitus, Type 2 / complications
  • Diabetic Neuropathies / diagnosis
  • Diabetic Neuropathies / metabolism
  • Diabetic Neuropathies / pathology*
  • Diabetic Neuropathies / physiopathology*
  • Down-Regulation*
  • Epidermis / innervation*
  • Epidermis / metabolism
  • Epidermis / pathology
  • Female
  • Humans
  • Japan
  • Kinetics
  • Male
  • Middle Aged
  • Nerve Fibers / metabolism
  • Nerve Fibers / pathology
  • Nerve Tissue Proteins / metabolism
  • Neural Conduction*
  • Polyneuropathies / complications
  • Polyneuropathies / diagnosis
  • Polyneuropathies / pathology*
  • Polyneuropathies / physiopathology*
  • Practice Guidelines as Topic
  • Severity of Illness Index
  • Ubiquitin Thiolesterase / metabolism

Substances

  • Nerve Tissue Proteins
  • UCHL1 protein, human
  • Ubiquitin Thiolesterase